Lisa Schnirring | News Editor | CIDRAP NewsJun 26, 2020At a cost of an estimated $31 billion, new vaccines, treatments, and diagnostics are urgently needed.
Huge global effort to fast-track COVID-19 tools advances
More from COVID-19More posts in COVID-19 »
- Moderna reports promising findings for next-generation COVID vaccine
- Study: COVID booster cuts severe COVID risk by a third in patients with weak immune systems
- Swedish study suggests link between long COVID and severity of illness
- Meta-analysis: Global COVID reinfection rate less than 1%, depending on variant, country, time